SPRY Total Non-Current Liabilities
Ars Pharmaceuticals Inc · Total Non-Current Liabilities
SPRY Total Non-Current Liabilities
Latest reported$176.12Mperiod ending
SPRY Quarterly Total Non-Current Liabilities ($3.32M → $176.12M)
Quarterly total non-current liabilities
High-resolution chart · PNG
SPRY total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 176,120,000 | |
| 176,651,000 | |
| 174,249,000 | |
| 174,271,000 | |
| 75,552,000 | |
| 70,722,000 | |
| 70,915,000 | |
| 0 | |
| 0 | |
| 0 | |
| 36,999 | |
| 92,000 | |
| 146,000 | |
| 199,000 | |
| 3,105,000 | |
| 5,518,000 | |
| 82,620,000 | |
| 4,431,000 | |
| 84,528,000 | |
| 5,080,000 | |
| 1,778,000 | |
| 2,055,000 | |
| 2,326,000 | |
| 3,324,000 |